Nicotine-induced changes in the metabolism of specific brain proteins.
The effect of acute and chronic nicotine on the metabolism of specific brain proteins was examined by measuring incorporation of labeled valine into protein, with densitometric scanning of proteins resolved by gel electrophoresis. Acute and chronic administration of nicotine (0.4 mg/kg per 30 min for 2 hours, s.c., or 0.5 mg/kg per 30 min for 5 days (Alzet mini-pump implanted subcutaneously] reduced incorporation of [14C]valine administered by approximately 6-7%. The results with chronic nicotine administration indicated a lack of tolerance for this effect of nicotine. Mecamylamine, a nicotinic ganglionic antagonist, does not seem to block the inhibition of protein synthesis. Small increases in protein content were observed in a high- and a low-molecular-weight region of SDS-polyacrylamide gel, used to separate proteins from newborn brain. In adult brain after chronic nicotine administration, selective increases and a decrease were seen in selective bands. Results are consonant with selective effects of nicotine on the synthesis or degradation of specific brain proteins.
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D004361:Drug Tolerance; D004591:Electrophoresis, Polyacrylamide Gel; D008464:Mecamylamine / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism*; D009538:Nicotine / Q000494:pharmacology*; D051381:Rats
D009419:Nerve Tissue Proteins; D008464:Mecamylamine; D009538:Nicotine